This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.

Back to overview
Alaeikhanehshir, Sena

Sena Alaeikhanehshir

Ph.D. Student


In July 2017, I finished my last medical internship at the Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital at the Department of Surgery and received my MD from the University of Amsterdam - Academic Medical Centre (UVA-AMC). During this internship, I came to know dr. Wesseling as the lead investigator and study coordinator of the LORD trial. This trial aims to test whether active surveillance of screen-detected low-grade DCIS, a commonly found lesion considered as a potential precursor of breast cancer, is as safe as conventional treatment. I was selected as MD PhD student focusing on further initiation, implementation and analysis of the trial.